arrow
A

Andrea Napolitano

Royal Marsden Hospital
H指数:31
被引数:4,048

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PLEOMORPHIC RHABDOMYOSARCOMA, OUTCOMES OF PATIENTS WITH ADVANCED DISEASE TREATED WITH SYSTEMIC AGENTS: RETROSPECTIVE STUDY FROM THE GLOBAL PUSHING ULTRA-RARE SARCOMAS TOWARDS HOPE (PUSH) CONSORTIUM

多形性横纹肌肉瘤,接受系统性药物治疗晚期疾病患者的结局:全球推动超罕见肉瘤走向希望(PUSH)联盟的回顾性研究

2026-03-080
OAAI
A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST)

一种新型辅助伊马替尼治疗后的风险评分可预测胃肠道间质瘤(GIST)患者的无复发生存期

2025-09-210
PREAI
Corrigendum to ‘Robotic MRI/CT Guided Multiregional ‘smart’ Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study’ [Acad Radiol 32/2 (2025) 1100-1107]

勘误:‘Robotic MRI/CT Guided Multiregional ‘smart’ Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study’ [Acad Radiol 32/2 (2025) 1100-1107]

2025-07-110
OAAI
UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants

英国临床实践指南:针对携带体细胞POT1致病性变异患者的管理

2025-05-110
PRE
Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study
2025-02-010
OAAI
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
2024-09-010
OAAI
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
2024-08-280
OAAI
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: An analysis from the OnCovid registry
2023-10-010
OA
Current management of benign retroperitoneal tumors
EJSO
IF2.9
2023-06-013
OAAI
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study (vol 171, pg 183, 2022)
2023-05-010
OAAI
BAP1 is a novel regulator of HIF-1α

BAP1是HIF-1α 的新型调节因子

2023-01-199
OAAI
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

临床实践中阿特珠单抗联合贝伐单抗治疗HCC的可重复安全性和有效性: AB-real研究的结果

2022-11-0156
OAAI